Intelgenx Technologies Corp (IGXT)
0.1666
+0.02
(+11.09%)
USD |
OTCM |
Apr 25, 16:00
Intelgenx Technologies Profit Margin (Quarterly): -323.9% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -323.9% |
| September 30, 2023 | -867.6% |
| June 30, 2023 | -2.15K% |
| March 31, 2023 | -1.80K% |
| December 31, 2022 | -1.59K% |
| September 30, 2022 | -1.88K% |
| June 30, 2022 | -649.2% |
| March 31, 2022 | -1.13K% |
| December 31, 2021 | -578.5% |
| September 30, 2021 | -337.6% |
| June 30, 2021 | -1.35K% |
| March 31, 2021 | -790.6% |
| December 31, 2020 | -161.6% |
| September 30, 2020 | -325.5% |
| June 30, 2020 | -3.93K% |
| March 31, 2020 | -1.22K% |
| December 31, 2019 | -3.91K% |
| September 30, 2019 | -4.60K% |
| June 30, 2019 | -1.32K% |
| March 31, 2019 | -622.1% |
| December 31, 2018 | -383.9% |
| September 30, 2018 | -420.6% |
| June 30, 2018 | -1.03K% |
| March 31, 2018 | -947.3% |
| December 31, 2017 | -74.62% |
| Date | Value |
|---|---|
| September 30, 2017 | -62.36% |
| June 30, 2017 | -59.15% |
| March 31, 2017 | -37.84% |
| December 31, 2016 | 19.68% |
| September 30, 2016 | 1.65% |
| June 30, 2016 | -125.0% |
| March 31, 2016 | -91.20% |
| December 31, 2015 | 17.78% |
| September 30, 2015 | 56.74% |
| June 30, 2015 | -47.01% |
| March 31, 2015 | -8.64% |
| December 31, 2014 | -31.03% |
| September 30, 2014 | -96.02% |
| June 30, 2014 | -383.8% |
| March 31, 2014 | -199.1% |
| December 31, 2013 | -447.2% |
| September 30, 2013 | -599.0% |
| June 30, 2013 | 16.45% |
| March 31, 2013 | -309.6% |
| December 31, 2012 | -31.35% |
| September 30, 2012 | |
| June 30, 2012 | -3.15K% |
| March 31, 2012 | -582.0% |
| December 31, 2011 | -269.5% |
| September 30, 2011 | -2.25K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.60K%
Minimum
Sep 2019
-161.6%
Maximum
Dec 2020
-1.52K%
Average
-1.22K%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -113.5% |
| Return on Invested Capital | -202.9% |
| Gross Profit Margin (Quarterly) | -27.00% |
| Operating Margin (Quarterly) | -462.7% |
| Return on Net Operating Assets | -127.5% |